PACS (PACS) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | $57.00 from $48.00 | Aug 10, 2026 |
| Truist Securities | Maintained | Buy | $62.00 from $52.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $57.00 from $52.00 | Aug 6, 2026 |
| UBS | Maintained | Buy | $60.00 from $57.00 | Aug 6, 2026 |
| UBS | Maintained | Buy | $57.00 from $50.00 | Jul 8, 2026 |
| Truist Securities | Maintained | Buy | $52.00 from $50.00 | May 18, 2026 |
| Oppenheimer | Maintained | Outperform | $48.00 from $42.00 | May 13, 2026 |
| Oppenheimer | Maintained | Outperform | $42.00 from $40.00 | Mar 4, 2026 |
| UBS | Maintained | Buy | $44.00 from $42.00 | Mar 4, 2026 |
| RBC Capital | Maintained | Outperform | $52.00 from $47.00 | Feb 27, 2026 |
| UBS | Maintained | Buy | $42.00 from $50.00 | Dec 18, 2025 |
| JP Morgan | Maintained | Overweight | $44.00 | Dec 17, 2025 |
| RBC Capital | Maintained | Outperform | $33.00 from $32.00 | Nov 20, 2025 |
| Truist Securities | Maintained | Buy | $32.00 from $46.00 | Jan 6, 2025 |
| Macquarie | Maintained | Outperform | $24.00 from $42.00 | Jan 6, 2025 |
| JP Morgan | Downgraded | Overweight → Neutral | $18.00 | Dec 17, 2024 |
| Stephens & Co. | Maintained | Overweight | $31.00 from $48.00 | Nov 18, 2024 |
| JP Morgan | Maintained | Overweight | $40.00 | Nov 6, 2024 |
| Truist Securities | Maintained | Buy | $46.00 from $44.00 | Oct 14, 2024 |
| UBS | Initiated Coverage | Buy | $50.00 | Oct 9, 2024 |
Frequently asked questions
What is the price target for PACS stock?
The average 12-month analyst price target for PACS (PACS) is $59.00, with a high estimate of $62.00 and a low of $57.00, across 4 analysts.
Is PACS a buy, sell, or hold?
Analysts covering PACS currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PACS?
The average price target of $59.00 implies 39.68% upside from the last price of $42.24.
What is the latest analyst rating on PACS?
On Aug 10, 2026, Oppenheimer maintained PACS at Outperform with a price target of $57.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.